Erythema infectiosum is a common, generally self-limiting childhood exanthem caused by parvovirus B19, characterized by a biphasic illness with an initial nonspecific febrile prodrome followed ~1 week later by the classic "slapped-cheek" facial rash and a lace-like reticular body rash. [1-2] While benign in most immunocompetent children, it carries significant risk in specific populations including pregnant women, patients with hemoglobinopathies, and immunocompromised individuals. [2-3]
1. History
- Prodrome: Low-grade fever, malaise, headache, myalgia, coryza occurring 7–10 days before rash onset (during viremic phase) [1]
- Rash timing: Bilateral "slapped-cheek" erythema appears first, followed 1–4 days later by a lace-like, reticular, erythematous rash on trunk and extremities [1][4]
- Rash recurrence: Evanescent — can wax and wane for weeks, provoked by sunlight, heat, bathing, exercise, or emotional stress [1]
- Joint symptoms: Arthralgias/arthritis more common in adults (especially women), symmetric, involving small joints of hands, wrists, knees [3][5]
- Pruritus: May accompany the rash [4]
- Exposure history: Sick contacts at school/daycare, known community outbreak, household exposure (50% seroconversion risk with household contact vs. 20–50% in classroom) [5]
- Important negatives: Absence of vesicles, oral lesions, conjunctivitis, lymphadenopathy helps distinguish from other exanthems
2. Alarm Features
- Pallor, tachycardia, fatigue → suspect transient aplastic crisis (especially in sickle cell disease, spherocytosis, thalassemia, iron deficiency anemia) [2][6]
- Pregnancy exposure → risk of hydrops fetalis, fetal death (fetal loss 8–17% before 20 weeks) [5][7]
- Petechial/purpuric rash → atypical presentation; must rule out meningococcemia, ITP, leukemia [8]
- Chest pain, dyspnea, signs of heart failure → parvovirus B19 myocarditis, particularly in young children (median age ~32 months); associated with 19.7% mortality/transplant/LVAD rate during the 2024 outbreak [9-10]
- Neurological symptoms (seizures, encephalitis, ataxia) → reported in 17.8% of hospitalized children during the 2024 outbreak [10]
- Immunocompromised patient with persistent anemia → chronic pure red cell aplasia [1-2]
3. Medications
- Treatment is supportive in immunocompetent patients [3][11]
- Antipyretics/analgesics: Acetaminophen or ibuprofen for fever and arthralgias
- NSAIDs: Useful for adult arthropathy (symmetric polyarthritis may persist weeks to months)
- IVIG: Indicated for chronic pure red cell aplasia in immunocompromised patients and may be considered in severe myocarditis [3][12]
- RBC transfusion: For transient aplastic crisis with significant anemia [6][13]
- No antiviral therapy is available; no vaccine currently approved [14]
- Antihistamines: May help if pruritus is prominent
4. Diet
- No specific dietary triggers or restrictions
- Encourage adequate hydration, especially during febrile prodrome
- No evidence-based dietary interventions for this condition
5. Review of Systems
- Constitutional: Fever, malaise, fatigue (prodromal)
- Skin: Rash character, distribution, timing relative to fever, pruritus
- MSK: Joint pain/swelling (especially in adults — hands, wrists, knees)
- Heme: Pallor, easy bruising, petechiae
- Cardiac: Chest pain, dyspnea, exercise intolerance, palpitations (myocarditis screen)
- Neuro: Headache, seizures, altered mental status
- OB/GYN: Pregnancy status, gestational age, fetal movement
6. Collateral History and Family History
- Daycare/school outbreak history — parvovirus B19 spreads in epidemic waves, especially late winter/spring [15-16]
- Household contacts with sickle cell disease or other hemoglobinopathies — at risk for concurrent aplastic crisis [6]
- Pregnant household members — critical to identify; the infected child is no longer contagious once the rash appears [5]
- Family history of hemolytic anemias (spherocytosis, G6PD deficiency, sickle cell disease)
- Immunocompromised family members (transplant recipients, HIV, chemotherapy)
7. Risk Factors
- Age: Peak incidence in school-age children (5–15 years) [16]
- Season: Late winter through early spring
- Occupation/exposure: Teachers, daycare workers, healthcare workers
- Hemoglobinopathies: Sickle cell disease, thalassemia, spherocytosis → risk of aplastic crisis [6][13]
- Immunosuppression: HIV, transplant recipients, chemotherapy → chronic infection/pure red cell aplasia [1-2]
- Pregnancy: ~35–40% of reproductive-age women are seronegative and susceptible [5]
- Post-COVID-19 pandemic surge: A significant increase in parvovirus B19 cases was observed in 2023–2024 across Europe and the US, likely due to waning population immunity [10][17]
8. Differential Diagnosis
- Rubella — similar maculopapular rash; distinguished by postauricular/suboccipital lymphadenopathy, Forchheimer spots [1]
- Measles (rubeola) — cephalocaudal spread, Koplik spots, higher fever, cough/coryza/conjunctivitis
- Scarlet fever — sandpaper rash, pharyngitis, strawberry tongue, Pastia lines [4]
- Roseola (HHV-6) — rash appears after fever resolves (vs. fifth disease where rash appears with/after mild fever) [4]
- Drug eruption — temporal relationship to medication
- Kawasaki disease — prolonged fever ≥5 days, conjunctival injection, mucositis, extremity changes, lymphadenopathy [18]
- Meningococcemia — petechial/purpuric rash with toxic appearance (cannot-miss diagnosis) [19]
- Systemic lupus erythematosus — malar rash can mimic slapped cheek; distinguished by systemic features
- Hand-foot-mouth disease — vesicular lesions on palms, soles, oral mucosa
9. Past Medical History
- Hemolytic anemias (sickle cell, spherocytosis, thalassemia) — highest risk for aplastic crisis [6][13]
- Immunodeficiency (congenital or acquired) — risk of chronic infection and pure red cell aplasia [1]
- Prior parvovirus B19 infection — IgG provides lifelong immunity; reinfection is rare [2]
- Pregnancy history and current pregnancy status
- Transplant history — solid organ or bone marrow transplant recipients at risk
- Chronic kidney disease — baseline anemia may worsen
10. Physical Exam
- Vital signs: Low-grade fever (often resolved by time of rash); tachycardia if anemic
- Face: Bilateral, confluent erythema of cheeks with circumoral pallor ("slapped cheek") [1][4]
- Trunk/extremities: Lace-like, reticular, erythematous maculopapular rash; may be evanescent [1]
- Joints: Swelling, tenderness (especially in adults — hands, wrists, knees)
- Skin: Check for petechiae/purpura (atypical variant); rash may be difficult to see in dark skin [1][8]
- Pallor: Suggests significant anemia — check conjunctivae, palms
- Cardiac: Gallop, murmur, hepatomegaly → concern for myocarditis [9]
- Abdomen: Hepatosplenomegaly (aplastic crisis, myocarditis)
- Absent findings: No lymphadenopathy, no oral lesions, no vesicles (helps distinguish from other exanthems)
11. Lab Studies
- Routine cases in immunocompetent children: No labs needed — diagnosis is clinical [11]
- Parvovirus B19 IgM/IgG serology: Confirmatory test of choice; ~90% of patients with erythema infectiosum have detectable IgM at presentation [2]
- CBC with reticulocyte count: Essential if aplastic crisis suspected — look for reticulocyte count <1%, significant drop in hemoglobin from baseline [6]
- Parvovirus B19 PCR (NAAT): Preferred in immunocompromised patients (who may not mount IgM response) and in aplastic crisis [2]
- CMP, LDH, haptoglobin, bilirubin: If hemolysis suspected
- Troponin, BNP/NT-proBNP: If myocarditis suspected [9]
- Pregnancy test: In reproductive-age women with exposure
12. Imaging
- Not routinely indicated in classic erythema infectiosum
- Echocardiography: If myocarditis suspected (chest pain, heart failure signs, troponin elevation) — assess LV function [9][20]
- Cardiac MRI: Gold standard for myocarditis diagnosis in stable patients [21]
- Fetal ultrasound with MCA Doppler: In pregnant women with confirmed infection — serial monitoring for hydrops fetalis and fetal anemia for 8–12 weeks after maternal infection [5][16]
- Chest X-ray: If respiratory distress or heart failure suspected
13. Special Tests
- No validated clinical scoring system specific to erythema infectiosum
- Bone marrow biopsy: Rarely needed; may show giant pronormoblasts (pathognomonic) in aplastic crisis [2]
- Endomyocardial biopsy: Gold standard for parvovirus B19 myocarditis confirmation; shows lymphocytic myocarditis with viral DNA on PCR [9][21]
- Fetal blood sampling (cordocentesis): For suspected severe fetal anemia; allows intrauterine transfusion [7][16]
14. ECG
- Not routinely indicated in uncomplicated erythema infectiosum
- Obtain ECG if: Chest pain, dyspnea, tachycardia out of proportion to fever, signs of heart failure
- Parvovirus B19 myocarditis ECG findings: Sinus tachycardia, nonspecific ST-T wave changes, T-wave inversions (inferior/lateral leads), low QRS voltage, peaked P waves [21-22]
- Danger signs: ST-segment elevation — associated with 100% mortality in one pediatric series; AV block, ventricular tachycardia [20][22]
15. Assessment
Erythema infectiosum is a benign, self-limiting illness in the vast majority of immunocompetent children, resolving in 1–2 weeks. [3][7] The disease is biphasic: an initial viremic phase (fever, malaise — patient is contagious) followed ~1 week later by the immune-mediated rash phase (patient is no longer contagious). [1][5]
Key clinical pearls:
- By the time the classic rash appears, the patient is no longer infectious — isolation is not necessary once the rash is present [5]
- Adults more commonly present with arthropathy rather than the classic slapped-cheek rash [5][23]
- The rash may be difficult to appreciate in dark skin [1]
- Atypical presentations include petechial/purpuric rash, "gloves and socks" syndrome, and vesiculopustular eruptions [2][8][24]
- The 2023–2024 post-pandemic surge highlighted myocarditis as a serious complication, particularly in children ≤7 years [9-10]
The following figure illustrates the pathophysiology of parvovirus B19 infection across different host populations — normal subjects, patients with hemolytic anemia (aplastic crisis), and immunocompromised patients (chronic anemia):
16. Treatment Plan
Immunocompetent children (classic fifth disease)
- Supportive care only — antipyretics (acetaminophen 15 mg/kg q4–6h or ibuprofen 10 mg/kg q6–8h), hydration, rest [3][11]
- Antihistamines for pruritus if needed
- Reassurance that the rash may recur for weeks with triggers (sun, heat, exercise) [1]
Adult arthropathy
Transient aplastic crisis (sickle cell, spherocytosis, etc.):
- RBC transfusion as needed for symptomatic anemia [6][13]
- Droplet isolation from pregnant women and other at-risk patients [6]
- Monitor siblings with hemoglobinopathies for concurrent aplastic crisis [6]
Immunocompromised patients with chronic pure red cell aplasia:
- IVIG (0.4 g/kg/day × 5–10 days or 1 g/kg/day × 2–3 days) [3][11]
- Reduction of immunosuppression if possible
Pregnancy
- Confirm infection with IgM/IgG serology [2]
- Serial fetal ultrasound + MCA Doppler every 1–2 weeks for 8–12 weeks [5][16]
- Referral to maternal-fetal medicine if hydrops or fetal anemia suspected [16]
- Intrauterine transfusion for severe fetal anemia (survival 67–85%) [14]
Myocarditis
- ICU-level care for hemodynamic instability [9]
- Standard heart failure management (inotropes, mechanical circulatory support including ECMO if needed) [20]
- IVIG and immunomodulatory therapy considered in select cases [12][21]
17. Disposition
Discharge criteria (majority of cases)
- Immunocompetent child or adult with classic presentation
- Well-appearing, hemodynamically stable
- No underlying hemoglobinopathy or immunodeficiency
- Adequate oral intake
Admission criteria
- Aplastic crisis with significant anemia requiring transfusion [6]
- Myocarditis — any signs of cardiac dysfunction (ICU admission in 71% of myocarditis cases during 2024 outbreak) [10]
- Severe anemia with hemodynamic compromise
- Neurological complications (encephalitis, seizures) [10]
- Diagnostic uncertainty with petechial rash requiring workup to exclude meningococcemia or leukemia [8]
Specialist consultation triggers
- Hematology: Aplastic crisis, chronic red cell aplasia
- Maternal-fetal medicine: Confirmed infection in pregnancy [16]
- Cardiology: Suspected myocarditis [9]
- Infectious disease: Immunocompromised patients with persistent infection
18. Follow Up / Return Precautions
Follow-up timing
- Routine cases: No specific follow-up needed unless symptoms persist >4 weeks
- Arthropathy in adults: PCP follow-up in 2–4 weeks if joint symptoms persist
- Pregnancy: Serial ultrasound/Doppler monitoring for 8–12 weeks post-infection [5][16]
- Post-aplastic crisis: Hematology follow-up with repeat CBC/reticulocyte count
Return precautions — advise return for
- New-onset pallor, fatigue, dizziness (worsening anemia)
- Chest pain, difficulty breathing, rapid heartbeat (myocarditis)
- Petechiae, purpura, or bleeding (thrombocytopenia)
- High fever, toxic appearance, neck stiffness
- Persistent or worsening joint swelling >6 weeks
Patient counseling
- The rash is not contagious once it appears — child may return to school/daycare [5]
- Rash may recur intermittently for weeks with sun, heat, or exercise — this is normal and does not indicate reinfection [1]
- Pregnant contacts should be informed and may need serologic testing [5]
- Lifelong immunity develops after infection [2]
- Expected recovery: 1–3 weeks for most cases; arthropathy may take longer in adults [23]
References
1. Parvovirus B19. — Young NS, Brown KE. The New England Journal of Medicine. 2004.
2. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
3. Erythema Infectiosum and Other Parvovirus B19 Infections. — Kirchner JT. American Family Physician. 1994.
4. Common Skin Rashes in Children. — Allmon A, Deane K, Martin KL. American Family Physician. 2015.
5. Practice Bulletin No. 151: Cytomegalovirus, Parvovirus B19, Varicella Zoster, and Toxoplasmosis in Pregnancy. — Committee on Practice Bulletins—Obstetrics Obstetrics and Gynecology. 2015.
6. Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report. — Yates AM, Aygun B, Nuss R, Rogers ZR. Pediatrics. 2024.
7. Prenatal Parvovirus B19 Infection. — Kagan KO, Hoopmann M, Geipel A, Sonek J, Enders M. Archives of Gynecology and Obstetrics. 2024.
8. Generalized Petechial Rashes in Children During a Parvovirus B19 Outbreak. — Edmonson MB, Riedesel EL, Williams GP, Demuri GP. Pediatrics. 2010.
9. Clinical Spectrum of Children With Parvovirus B19-Associated Acute Myocarditis. — Ammirati E, Veronese G, Raimondi F, et al. Circulation. 2026.
10. Severe Presentations and Outcomes in Hospitalized Pediatric Patients With Parvovirus B19 Infection During the 2024 Outbreak: A Multicenter Prospective Study in Italy. — Venturini E, Tamborino AM, Arrichiello G, et al. The Pediatric Infectious Disease Journal. 2025.
11. Clinical Presentations of Parvovirus B19 Infection. — Servey JT, Reamy BV, Hodge J. American Family Physician. 2007.
12. Parvovirus B19-Associated Myocarditis in Children: A Systematic Review of Clinical Features, Management and Outcomes. — Veronese G, Colombo G, Garascia A, et al. European Journal of Clinical Investigation. 2025.
13. Significance of Parvovirus B19 Infection in Childhood - Collection of Demographic Data, Clinical Presentation, Diagnostic Findings and the Impact on Patients With Hemolytic Anemia. — Lawatsch L, Baier M, Milde T, Gruhn B. Diagnostic Microbiology and Infectious Disease. 2026.
14. Parvovirus B19 Infection in Pregnancy - A Review. — Gigi CE, Anumba DOC. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2021.
15. Academy Rash. A Probable Epidemic of Erythema Infectiosum ('Fifth Disease'). — Brass C, Elliott LM, Stevens DA. The Journal of the American Medical Association. 1982.
16. Parvovirus B19 in Pregnancy: A Case Review. — Hunter LA, Ayala NK. Journal of Midwifery & Women's Health. 2021.
17. Is Parvovirus B19 Infection Upsurge in 2023-2024 Associated With Adverse Pregnancy Outcome?. — Prasad S, Khalil A, Yinon Y, et al. Ultrasound in Obstetrics & Gynecology : The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2025.
18. The Rash With Maculopapules and Fever in Children. — Muzumdar S, Rothe MJ, Grant-Kels JM. Clinics in Dermatology. 2019.
19. Evaluating the Febrile Patient With a Rash. — McKinnon HD, Howard T. American Family Physician. 2000.
20. Parvovirus B19 Myocarditis in Children: An Observational Study. — Vigneswaran TV, Brown JR, Breuer J, Burch M. Archives of Disease in Childhood. 2016.
21. Parvovirus B19 Myocarditis in Children: A Diagnostic and Therapeutic Approach. — Esmel-Vilomara R, Dolader P, Izquierdo-Blasco J, et al. European Journal of Pediatrics. 2022.
22. Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association. — Law YM, Lal AK, Chen S, et al. Circulation. 2021.
23. Acute Parvovirus B19 Infection: Analysis of 46 Patients. — Tomás-Velázquez A, Escribano Á, Rodríguez-Garijo N, et al. Medicina Clinica. 2020.
24. Human Parvovirus B19-Induced Vesiculopustular Skin Eruption. — Naides SJ, Piette W, Veach LA, Argenyi Z. The American Journal of Medicine. 1988.